Catalyst Wire Dossier Catalyst Wire Dossier

Levocetirizine/Pseudoephedrine

levocetirizine/pseudoephedrine · Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levocetirizine/Pseudoephedrine, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil [Phase 3]

See pricing